European stocks steady ahead of key US consumer inflation data By Investing.com
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 13 2024
0mins
Should l Buy CL?
Source: Investing.com
European Stock Markets: European stock markets remained stable as investors awaited US inflation data, with mixed performance across major indices; the DAX was flat, CAC 40 fell slightly, and FTSE 100 gained marginally.
Corporate Developments: Just Eat Takeaway's stock surged after selling Grubhub for $650 million, while Siemens Energy shares rose significantly despite not proposing a dividend, and oil prices increased slightly following OPEC's downgraded demand forecasts.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CL
Wall Street analysts forecast CL stock price to rise
15 Analyst Rating
10 Buy
4 Hold
1 Sell
Moderate Buy
Current: 85.360
Low
77.00
Averages
87.79
High
95.00
Current: 85.360
Low
77.00
Averages
87.79
High
95.00
About CL
Colgate-Palmolive Company is a growth company. It is focused on Oral Care, Personal Care, Home Care and Pet Nutrition, it sells its products under brands, such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. Its Oral, Personal and Home Care product segment is managed geographically in five segments, such as North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell primarily to a variety of traditional and e-commerce retailers, wholesalers, distributors, dentists and skin health professionals. Its Pet Nutrition products include specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The customers for Pet Nutrition products are authorized pet supply retailers, veterinarians and e-commerce retailers.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Stock Performance: Shares of Colgate-Palmolive increased by approximately 2% following the release of their Q1 results.
- Earnings Report: The company's quarterly results exceeded market expectations, contributing to the rise in stock value.
See More
- Earnings Beat: Out of 12 consumer staples companies reporting last week, 11 exceeded EPS estimates, indicating strong profitability despite overall volume pressures, showcasing the companies' effective pricing power.
- Coca-Cola Growth: Coca-Cola (KO) reported a 3% increase in global unit case volume in Q1, with all segments performing positively, which boosted the broader consumer staples sector and highlighted its sustained market leadership.
- Altria Performance: Altria Group (MO) saw a 3.2% revenue increase to $5.43 billion in Q1, with adjusted EPS at $1.32, demonstrating its ability to offset declining shipment volumes through pricing power amid weak consumer demand in the tobacco sector.
- Increased Competition: Hershey (HSY) beat Q1 estimates, yet faced a decline in market share due to intensified competition, reflecting how shifts in consumer preferences under high pricing conditions can impact corporate strategies.
See More
- Escalation Probability: BCA Research warns of a 70% chance of re-escalation of the Iran war within the next 12 months, even if oil shipping through the Strait of Hormuz partially resumes, highlighting increasing geopolitical risks.
- Iran's Strategy: Chief geopolitical strategist Matt Gertken notes that Iran has prolonged the closure of the strait to keep oil prices high while negotiating without commitment, indicating a potentially worsening situation.
- U.S. Response: The U.S. has imposed a naval blockade to pressure Iran into abandoning its nuclear program, with BCA identifying the nuclear dispute as a key obstacle to a durable ceasefire, suggesting future negotiations may fail due to this complexity.
- Investment Strategy Adjustment: BCA is closing bullish trades linked to ceasefire optimism for small gains while maintaining long positions in U.S. energy stocks, which have risen 5.6% since April 15, and reopening a global defensives versus cyclicals trade.
See More

- Performance Beat: Colgate-Palmolive reported net sales of $5.32 billion for Q1, exceeding analysts' expectations of $5.22 billion, reflecting strong international demand despite challenges in the U.S. market from budget-conscious consumers.
- Profitability Boost: Adjusted earnings per share reached $0.97, surpassing the $0.95 estimate, driven by steady demand for household staples like toothpaste and manual toothbrushes, even amid rising raw material and tariff pressures.
- Market Dynamics Shift: While North American segment volumes fell by 3.2%, overall volumes increased by 1.1%, with a 2.2% price rise, indicating consumer preference for lower-priced alternatives due to high living costs, while showcasing the company's resilience in international markets.
- Macroeconomic Challenges: Colgate anticipates significant inflationary pressures ahead, particularly from rising oil and commodity prices, and while reaffirming annual sales and profit forecasts, it remains cautious about market growth in 2026.
See More
- Significant Revenue Growth: Colgate-Palmolive reported Q1 revenue of $5.32 billion, an 8.4% increase year-over-year, exceeding analyst expectations and demonstrating strong performance across all categories and four out of five divisions, bolstering market confidence.
- Organic Sales Performance: While organic sales in North America fell by 1.8%, Latin America and Asia Pacific saw increases of 5.4% and 5.6% respectively, indicating the company's competitive strength and adaptability in global markets.
- Improved Profitability: The non-GAAP EPS of $0.97 surpassed market expectations by $0.03 and increased by $0.06 compared to the previous year, reflecting the company's success in cost control and pricing strategies.
- Optimistic Future Outlook: The company expects net sales growth of 2% to 6% for 2026, with organic sales growth projected at 1% to 4%, showcasing Colgate's ongoing investment potential in advertising spending and market share.
See More










